Additional investigation reveals that estrogen diminishes the capacity of auranofin to elicit IL-6/hepcidin signal in Huh7 cells, offering a molecular rationale for auranofin's ineffectiveness in female Hfe/ mice
10.1016/j.jare.2016.04.001 37 ZhangY.ZhaoL.LiuY.ZhangJ.ZhengL.ZhengM
Allure reached out to the manufacturers of popular GLP-1 drugs: Lilly (the makers of Zepbound and Mounjaro) and Novo Nordisk (the company behind Ozempic) to ask if they could comment as to if a change in ones sense of smell is a known side effect of such medications
We propose that integrating biophysical targeting with electromagnetic engineering holds promise to redefine PCa management through mechanism-driven precision
Chandran, R., Thangaraj, P., Saravanan, S., Sajeesh, T., & Arunachalam, K